Home idenix
 

Keywords :   


Tag: idenix

Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

2014-12-01 14:52:54| Biotech - Topix.net

The CEO who sold Idenix Pharmaceuticals to Merck & Co. in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.

Tags: sale head ceo cambridge

 

Former CEO who oversaw $3.9B sale of Idenix to head new Cambridge biotech

2014-12-01 14:52:53| Biotech - Topix.net

The CEO who sold Idenix Pharmaceuticals to Merck & Co . in August for $3.9 billion, the area's largest biotech acquisition this year, has a new job.

Tags: sale head ceo cambridge

 
 

Merck Completes Tender Offer to Acquire Idenix

2014-08-05 12:00:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced the successful completion of the tender offer for all of the outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) at a purchase price of $24.50 per share. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461orInvestors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: offer acquire tender completes

 

Merck starting tender offer for Idenix

2014-06-20 17:00:20| Biotech - Topix.net

Merck is starting a tender offer on Friday to buy all of the outstanding shares of hepatitis C treatment maker Idenix Pharmaceuticals Inc. Merck & Co.

Tags: offer starting tender merck

 

Merck Begins Tender Offer to Acquire Idenix

2014-06-20 13:30:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX). On June 09, 2014, Merck announced its intent to acquire Idenix. Language: English Contact: Media:Pamela Eisele, 267-305-3558Steve Cragle, 908-423-3461Investors:Joe Romanelli, 908-423-5185Justin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: offer begins acquire tender

 

Sites : [1] [2] next »